↓ Skip to main content

Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model

Overview of attention for article published in Tumor Biology, February 2015
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
27 Mendeley
Title
Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model
Published in
Tumor Biology, February 2015
DOI 10.1007/s13277-015-3178-8
Pubmed ID
Authors

Wei Da, Jinshui Zhu, Long Wang, Qun Sun

Abstract

This study aimed to assess the effects of curcumin on lymphatic vessel density (LVD) in an in vivo model of gastric cancer using the gastric cancer cell line, SGC-7901. Gastric tumor-bearing nude mice were treated with saline or 40, 80, or 160 mg kg(-1) day(-1) curcumin for 8 weeks. The results indicated that the tumor volumes were significantly lower in mice treated with 80 and 160 mg kg(-1) day(-1) curcumin as compared with that of the control group (both P < 0.001). In addition, both 80 and 160 mg kg(-1) day(-1) curcumin significantly reduced LVD (both P < 0.01). Although immunohistochemical analysis showed that curcumin did not significantly alter the expression of prospero homeobox 1 (Prox-1), podoplanin, and vascular endothelial growth factor receptor 3 (VEGFR-3), 160 mg kg(-1) day(-1) curcumin significantly decreased the expression of Prox-1, podoplanin, and VEGFR-3 levels as detected by Western blot analysis (P ≤ 0.03). Downregulation of lymphatic vessel endothelial receptor 1 (LYVE-1), Prox-1, podoplanin, and VEGFR-3 mRNA expression by curcumin was also detected (all P < 0.05). Furthermore, the apoptosis rates of tumor cells increased with curcumin in a concentration-dependent manner (all P < 0.001). Thus, curcumin may inhibit gastric cancer lymph node metastasis. Our findings provide theoretical evidence and an experimental basis for further analysis of the clinical application of curcumin in the therapy of gastric cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 4%
Unknown 26 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 22%
Student > Ph. D. Student 5 19%
Student > Bachelor 4 15%
Researcher 3 11%
Student > Doctoral Student 2 7%
Other 3 11%
Unknown 4 15%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 15%
Biochemistry, Genetics and Molecular Biology 4 15%
Agricultural and Biological Sciences 3 11%
Medicine and Dentistry 3 11%
Nursing and Health Professions 2 7%
Other 4 15%
Unknown 7 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2016.
All research outputs
#20,433,667
of 22,986,950 outputs
Outputs from Tumor Biology
#1,843
of 2,630 outputs
Outputs of similar age
#302,026
of 358,493 outputs
Outputs of similar age from Tumor Biology
#98
of 168 outputs
Altmetric has tracked 22,986,950 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,630 research outputs from this source. They receive a mean Attention Score of 2.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,493 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.